Three Separate Clinical Entities of Infective Endocarditis-A Population-Based Study From Southern Finland 2013-2017

Mika Halavaara1, Timi Martelius1, Veli-Jukka Anttila1

  • 1Department of Infectious Diseases, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Insights

Health care-associated infective endocarditis (HAIE) and intravenous drug use-related IE (IDUIE) are significant groups. This study highlights their distinct clinical features and outcomes, emphasizing the need to recognize IDUIE as a separate risk group.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Epidemiology

Background:

  • Infective endocarditis (IE) encompasses health care-associated (HAIE) and intravenous drug use-related (IDUIE) forms.
  • These groups represent major challenges in IE management.
  • Their specific roles and clinical presentations require detailed investigation.

Purpose of the Study:

  • To analyze the distinct clinical characteristics and outcomes of community-acquired IE (CAIE), HAIE, and IDUIE.
  • To assess the epidemiological significance of IDUIE in a population-based setting.
  • To inform clinical recognition and management strategies for different IE risk groups.

Main Methods:

  • A population-based retrospective study of adult IE patients in Southern Finland (2013-2017).
  • IE episodes were categorized into CAIE, HAIE, and IDUIE based on acquisition mode.
  • Statistical analysis compared patient demographics, etiology, valve involvement, and mortality rates across groups.

Main Results:

  • The study included 313 IE episodes with an overall incidence of 6.48/100,000 person-years.
  • CAIE, HAIE, and IDUIE each accounted for approximately one-third of cases.
  • IDUIE patients were younger, with higher rates of right-sided IE and Staphylococcus aureus etiology compared to CAIE.
  • HAIE patients exhibited more comorbidities, prosthetic valve involvement, and significantly higher mortality rates than CAIE patients.

Conclusions:

  • Intravenous drug use-related IE (IDUIE) should be recognized as a distinct major risk group, separate from community-acquired IE (CAIE), especially in regions with high drug use prevalence.
  • Health care-associated IE (HAIE) presents with distinct risk factors and poorer outcomes compared to CAIE.
  • A tripartite classification of IE (CAIE, HAIE, IDUIE) is crucial for understanding variable characteristics and outcomes.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...